SBIO vs. HRTS ETF Comparison
Comparison of ALPS Medical Breakthroughs ETF (SBIO) to Tema Cardiovascular and Metabolic ETF (HRTS)
SBIO
ALPS Medical Breakthroughs ETF
SBIO Description
The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.
Grade (RS Rating)
Last Trade
$32.16
Average Daily Volume
11,955
84
HRTS
Tema Cardiovascular and Metabolic ETF
HRTS Description
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund advisor generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.Grade (RS Rating)
Last Trade
$30.90
Average Daily Volume
29,081
9
Performance
| Period | SBIO | HRTS |
|---|---|---|
| 30 Days | -9.65% | -9.01% |
| 60 Days | -11.74% | -7.46% |
| 90 Days | -1.93% | -1.40% |
| 12 Months | 9.54% |
0 Overlapping Holdings
| Symbol | Grade | Weight in SBIO | Weight in HRTS | Overlap |
|---|
SBIO Overweight 84 Positions Relative to HRTS
| Symbol | Grade | Weight | |
|---|---|---|---|
| CERE | A | 5.17% | |
| VKTX | B | 4.62% | |
| PCVX | D | 4.47% | |
| RVMD | A | 4.05% | |
| ALPN | A | 2.87% | |
| ALKS | D | 2.75% | |
| AXSM | D | 2.35% | |
| CRNX | B | 2.34% | |
| SWTX | C | 2.2% | |
| XENE | D | 2.1% | |
| ACLX | D | 1.95% | |
| IDYA | C | 1.95% | |
| IMCR | D | 1.94% | |
| ACAD | F | 1.87% | |
| SMMT | C | 1.77% | |
| CLDX | D | 1.65% | |
| RYTM | D | 1.63% | |
| CORT | D | 1.61% | |
| MRUS | B | 1.6% | |
| ARVN | D | 1.57% | |
| DNLI | F | 1.52% | |
| VCEL | C | 1.52% | |
| VERA | D | 1.47% | |
| NTLA | F | 1.4% | |
| RNA | A | 1.36% | |
| KROS | C | 1.35% | |
| GLPG | F | 1.32% | |
| GERN | A | 1.3% | |
| SNDX | C | 1.21% | |
| AGIO | A | 1.21% | |
| CPRX | D | 1.18% | |
| INBX | D | 1.1% | |
| PTGX | D | 1.06% | |
| ZLAB | F | 1.01% | |
| DAWN | D | 0.99% | |
| EWTX | C | 0.99% | |
| MORF | F | 0.98% | |
| KURA | C | 0.97% | |
| RCUS | D | 0.95% | |
| IRWD | F | 0.88% | |
| TARS | D | 0.86% | |
| VRNA | F | 0.85% | |
| FDMT | D | 0.84% | |
| AKRO | F | 0.8% | |
| DCPH | C | 0.8% | |
| MIRM | D | 0.77% | |
| XNCR | D | 0.76% | |
| MNKD | C | 0.76% | |
| PRTA | F | 0.75% | |
| VIR | F | 0.74% | |
| MGNX | D | 0.68% | |
| LQDA | D | 0.67% | |
| MDXG | F | 0.65% | |
| VRDN | F | 0.61% | |
| BCRX | F | 0.61% | |
| ZNTL | F | 0.6% | |
| OPK | B | 0.59% | |
| ETNB | F | 0.57% | |
| SPRY | D | 0.55% | |
| ARCT | F | 0.51% | |
| PLRX | F | 0.51% | |
| AUPH | F | 0.5% | |
| KNSA | C | 0.48% | |
| AVTE | D | 0.44% | |
| IRON | F | 0.44% | |
| SVRA | D | 0.43% | |
| ALLO | F | 0.38% | |
| OLMA | F | 0.37% | |
| CMPS | F | 0.36% | |
| ANAB | C | 0.35% | |
| ALEC | D | 0.35% | |
| MLYS | C | 0.32% | |
| FULC | D | 0.31% | |
| TVTX | F | 0.3% | |
| BMEA | F | 0.27% | |
| ITOS | F | 0.27% | |
| REPL | F | 0.27% | |
| AURA | D | 0.24% | |
| AVXL | F | 0.2% | |
| RAPT | F | 0.19% | |
| ENTA | F | 0.19% | |
| VNDA | B | 0.18% | |
| INZY | F | 0.18% | |
| RPHM | D | 0.04% |
SBIO: Top Represented Industries & Keywords
HRTS: Top Represented Industries & Keywords
Compare ETFs
